Renaissance Capital LLC Sells 18,998 Shares of Astera Labs, Inc. $ALAB

Key Points

• Renaissance Capital LLC has reduced its stake in Astera Labs by 13.0%, now holding 126,623 shares valued at approximately $11.4 million, making it the firm's fourth largest position.
• Insiders sold a significant amount of Astera Labs stock recently, with Director Manuel Alba selling 183,000 shares for over $31 million, reflecting a 32.17% decrease in their holdings.
• Astera Labs reported a 149.5% increase in revenue year-over-year for the last quarter, with earnings per share surpassing analysts' expectations at $0.44.

Renaissance Capital LLC trimmed its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 13.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 126,623 shares of the company's stock after selling 18,998 shares during the quarter. Astera Labs comprises 8.0% of Renaissance Capital LLC's portfolio, making the stock its 4th largest position. Renaissance Capital LLC owned approximately 0.08% of Astera Labs worth $11,449,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Hoey Investments Inc. raised its position in shares of Astera Labs by 4.2% during the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock worth $298,000 after purchasing an additional 200 shares during the period. Sound Income Strategies LLC increased its position in Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after acquiring an additional 204 shares during the period. Allworth Financial LP increased its position in Astera Labs by 20.4% in the 1st quarter. Allworth Financial LP now owns 1,394 shares of the company's stock valued at $90,000 after acquiring an additional 236 shares during the period. GAMMA Investing LLC increased its position in Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after acquiring an additional 284 shares during the period. Finally, Wealthcare Advisory Partners LLC increased its position in Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company's stock valued at $1,727,000 after acquiring an additional 320 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares of the company's stock, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the completion of the sale, the general counsel directly owned 161,573 shares of the company's stock, valued at approximately $30,488,825.10. The trade was a 5.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,576,027 shares of company stock worth $239,177,011 in the last 90 days. 12.50% of the stock is owned by corporate insiders.

Astera Labs Trading Up 0.5%

Shares of NASDAQ ALAB opened at $198.80 on Tuesday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The business has a 50-day moving average price of $183.42 and a two-hundred day moving average price of $116.20. The firm has a market capitalization of $33.04 billion, a PE ratio of 355.00, a PEG ratio of 5.02 and a beta of 1.46.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm's revenue was up 149.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. Needham & Company LLC increased their price target on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a research note on Tuesday, September 2nd. Citigroup raised their price objective on Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research note on Wednesday, September 17th. Finally, Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $152.94.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.